Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;26(4):484-98.
doi: 10.1038/cr.2016.31. Epub 2016 Mar 22.

Drugging the undruggables: exploring the ubiquitin system for drug development

Xiaodong Huang  1 , Vishva M Dixit  2
Affiliations
Review

Drugging the undruggables: exploring the ubiquitin system for drug development

Xiaodong Huang et al. Cell Res. 2016 Apr.

Abstract

Dynamic modulation of protein levels is tightly controlled in response to physiological cues. In mammalian cells, much of the protein degradation is carried out by the ubiquitin-proteasome system (UPS). Similar to kinases, components of the ubiquitin system are often dysregulated, leading to a variety of diseases, including cancer and neurodegeneration, making them attractive drug _targets. However, so far there are only a handful of drugs _targeting the ubiquitin system that have been approved by the FDA. Here, we review possible therapeutic intervention nodes in the ubiquitin system, analyze the challenges, and highlight the most promising strategies to _target the UPS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of the ubiquitin system and possible intervention nodes. Ubiquitination is an ATP-dependent process carried out by three classes of enzymes. E1 activating enzymes form a thioester bond with ubiquitin, followed by subsequent binding of ubiquitin to E2 conjugating enzymes, and ultimately the formation of an isopeptide bond between the carboxyl-terminal glycine of ubiquitin and a lysine residue on the substrate protein, which requires E3 ubiquitin ligases. Multiple intervention nodes in the reaction cascade have been proposed to either block or enhance ubiquitination.
Figure 2
Figure 2
SCFSKP2 as a possible anti-cancer _target. (A) The crystal structure of SCFSKP2 highlights potential interfaces (pockets 1-3) that small molecule inhibitors can bind to and block its E3 ligase function. (B) Compound 25 has been identified to be a selective SCFSKP2 inhibitor. It blocks ubiquitination and degradation of p27, as well as ubiquitination and activation of AKT. Together, this compound exhibits potent antitumor activities in multiple animal models.
Figure 3
Figure 3
MDM2 as a potential anti-cancer _target. p53 is rapidly ubiquitinated by MDM2 and degraded via the proteasome. Nutlins (and other MDM2/p53 interaction inhibitors) disrupt the interaction between MDM2 and p53, resulting in accumulation of p53 and its anti-tumor effect.
Figure 4
Figure 4
Rationales of enhancing ubiquitination. (A) Auxin is a plant hormone that directly binds to the F-box protein TIR1. With the support of co-factor InsP6, auxin promotes TIR1 interaction with the substrate proteins, AUX/IAAs, leading to enhanced ubiquitination and degradation of substrates. (B) Binding of endogenous substrates to CRBN is blocked by IMiDs molecules, whereas IMiDs recruit neo-substrates (for example: IKZF1 and IKZF3) to CRBN, leading to the stabilization of endogenous substrates but degradation of neo-substrates.
Figure 5
Figure 5
PROTAC as an anti-cancer strategy. (A) PROTACs are bifunctional molecules that are comprised of a _targeting ligand tethered to an E3 ligase-recruiting moiety through a short linker. (B) dBET1 as an example of PROTAC. dBET1 is comprised of JQ1 that binds to oncoprotein BRD4, and thalidomide that recruits CRL4CRBN, an E3 ubiquitin ligase.
Figure 6
Figure 6
Hydrophobic tagging as an anti-cancer strategy. A partially unfolded protein is assisted by the chaperone machinery to refold back into its native conformation. Proteasome-dependent degradation is triggered if chaperone machinery fails to refold a damaged protein. Hydrophobic tagging molecules are bifunctional molecules comprised of a substrate-recruiting ligand connected with a hydrophobic moiety, such as adamantane. A protein binding to a hydrophobic tagging molecule mimics partially unfolded state to trigger _target protein degradation by either directly escorting _target to proteasome or initiating ubiquitination of _target protein.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem 2012; 81: 203–229. - PubMed
    1. Wickliffe KE, Williamson A, Meyer HJ, Kelly A, Rape M. K11-linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol 2011; 21:656–663. - PMC - PubMed
    1. Newton K, Matsumoto ML, Wertz IE, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134:668–678. - PubMed
    1. Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. 2008; Cell 133:653–665. - PMC - PubMed
    1. Walczak H, Iwai K, Dikic I. Generation and physiological roles of linear ubiquitin chains. BMC Biol 2012; 10:23–23. - PMC - PubMed

MeSH terms

  NODES
twitter 2